Advancing Towards Personalized Prescription of Radiotherapy Dose

ElsevierVolume 33, Issue 3, July 2023, Pages 219-220Seminars in Radiation OncologyAuthor links open overlay panel, Section snippetsConflict of Interest

Dr. Citrin has no confilcts of interest to report. Dr. Morris reports the following potential conflicts of interest: Archeus Technologies – Scientific Advisory Board Member with stock options, Seneca Therapeutics – Scientific Advisory Board Member with stock options, NorthStar Medical Isotopes - Scientific Advisory Board Member with compensation, Wisconsin Alumni Research Foundation – Patents filed and approved related to radiation and immunotherapies for cancer.

View full text

Published by Elsevier Inc.

留言 (0)

沒有登入
gif